## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-06-24T01:16:03.797Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Depression Cognitive Research" developer_entity: "CogniFit" bundle_id: "com.cognifit.ios.depression" app_store_id: "1412024285" google_play_id: "com.cognifit.android.depression" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2025-09-29" report_date: "2026-06-24" last_verified: "2026-06-24" report_version: "4.7.5" total_reviews: 0 confidence: "low" confidence_score: 0.3 data_age_days: 0 momentum_velocity: "maintenance" intelligence_version: 3 nemesis: "Migraine Buddy: Track Headache" competitor_count: 7 tags: ["medical", "freemium", "mobile app", "app review", "app analysis", "healthcare", "professionals,", "researchers,"] canonical_url: "https://marlvel.ai/intel-report/medical/depression-cognitive-research" license: "CC-BY-NC 4.0" content_version: "v2" --- # Depression Cognitive Research App Audit ## TL;DR {#tldr} - **Category**: Medical · Freemium > **TL;DR:** Depression Cognitive Research is a medical app by CogniFit, available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Depression Cognitive Research is a medical app by CogniFit. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | CogniFit | | **Pricing** | Freemium | | **Platforms** | iOS & Android | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** CogniFit - **Category:** Medical - **Target Audience:** Healthcare professionals, researchers, and individuals seeking to monitor or improve cognitive health through scientifically-validated digital tools. - **Platforms:** iOS & Android - **Version Audited:** 4.7.5 - **Audit Date:** 2026-06-24 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 1412024285 - **Bundle ID:** com.cognifit.ios.depression - **Google Play ID:** com.cognifit.android.depression - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-06-24 ## Executive Snapshot **What it is:** Depression Cognitive Research is a medical app providing digital cognitive assessment and stimulation tools for neuroscience researchers and clinical study participants. **Why users hire it:** Researchers hire this tool to standardize cognitive data collection across diverse populations, while individuals use it to monitor cognitive health markers associated with mood disorders. ## App DNA (Features & Intent) - **[Differentiator] Cognitive Assessment Battery (CAB):** Standardized digital tests measuring 20+ cognitive domains including attention, memory, and processing speed * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Personalized Training Plans:** AI-driven training schedules that adapt difficulty levels based on user performance in cognitive tasks * *User Intent:* Users value self-expression and personalized experiences. - **[Standard] Progress Monitoring Reports:** Detailed analytics tracking cognitive development and identifying potential function deficits over time * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} The app maintains a research-focused position in the Medical category, though the lack of rating volume across both platforms suggests it has yet to achieve consumer-facing market penetration. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free trial with 10 licenses, Subscription-based access for individuals, families, and professionals - **Analysis:** Freemium model uses a 10-license free trial to seed B2B and family adoption, converting users into recurring subscription revenue. ## SWOT Analysis {#swot} **Core Strengths:** - Scientific validation across 20+ cognitive domains provides a professional-grade barrier to entry - AI-driven training plans reduce churn by tailoring difficulty to user skill **Critical Frictions:** - Zero rating volume indicates lack of consumer traction - 10-license trial model lacks clear individual conversion path **Growth Levers:** - Untapped education partnerships for B2B distribution - Integration of wearable data to bridge hardware with cognitive insights **Market Threats:** - High-velocity competitors like Sword Health using AI-driven feedback - Lack of gamification leaves the app vulnerable to symptom-tracking rivals like Migraine Buddy ## Recent Changes (v2 → v3) {#recent-changes} The report identifies a transition from a passive research-only tool to a product struggling with a B2B-centric pricing model that limits consumer growth. **Overall trend**: Mixed **Compared at**: 2026-06-24 ### High-impact changes - **[Shifted] Pricing Model Pivot** (pricing) — Pricing model shifted from 'free' to 'freemium', highlighting the 10-license trial as a conversion bottleneck for individual users. - **[Shifted] Strategic Positioning** (positioning) — Executive summary shifted from a neutral research tool overview to a critical assessment of the app's vulnerability in the consumer health-tracking market. ### Medium-impact changes - **[Improved] Feature Competitive Positioning** (features) — Cognitive Assessment Battery and Personalized Training Plans were reclassified from 'standard' to 'differentiator' status. - **[Added] SWOT Analysis Inclusion** (swot) — Added formal SWOT analysis identifying zero rating volume as a weakness and gamified competitors as a primary threat. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Depression Cognitive Research vs Migraine Buddy: Track Headache — Head to Head - **[Migraine Buddy: Track Headache](https://marlvel.ai/intel-report/medical/com-healint-migrainebuddy)** by Voluntis: This is the most mature symptom-tracking competitor in the medical category with a massive, highly-engaged user base. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Provides comprehensive longitudinal symptom mapping that allows users to identify specific environmental and behavioral triggers. - Integrates advanced data export features that enable patients to share detailed health reports directly with physicians. ### Contenders (Strong Challengers) - **[mySugr - Diabetes Tracker Log](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr)** by mySugr GmbH [Moat: High]: A dominant player in chronic condition management that excels at gamifying the daily logging experience. - Utilizes gamification mechanics like point-based challenges to drive daily user engagement and consistent data logging. - Offers seamless integration with continuous glucose monitors to automate data entry and reduce user friction. - **[Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe)** by MediSafe Inc. [Moat: Medium]: A high-velocity competitor that has successfully captured the medication adherence niche through superior UX. - Features a robust, multi-layered notification system that ensures medication adherence through persistent, customizable patient reminders. - Includes a family-sharing feature that allows caregivers to monitor medication compliance for elderly or dependent patients. ### Peers (What They Do Better) - **[Kardia](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg)** by AliveCor, Inc.: A specialized medical device companion app that demonstrates how to bridge hardware data with patient-facing insights. - Provides clinical-grade ECG analysis directly to the user, establishing a high barrier to entry for software-only competitors. - Maintains a strict regulatory-compliant workflow that builds significant trust with both patients and healthcare providers. - **[Spruce: Medical Communication](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live)** by Spruce Health: Focuses on the communication layer of healthcare, providing a template for secure patient-provider interaction. - Offers a secure, HIPAA-compliant messaging platform that replaces standard SMS for sensitive clinical communication. - Supports asynchronous telehealth workflows that allow providers to manage patient inquiries without requiring real-time video sessions. ### New Kids on the Block (What's Innovative) - **[Sword Health: AI Care](https://marlvel.ai/intel-report/medical/com-swordhealth-guarda-ios)** by Sword Health, Inc: An aggressive newcomer leveraging AI to provide personalized physical therapy, showing high release velocity. - **[VA: Health and Benefits](https://marlvel.ai/intel-report/medical/gov-va-vamobileapp)** by US Department of Veterans Affairs (VA): A rapidly evolving government-backed platform that is setting new standards for comprehensive patient portal access. ## App Momentum (Maintenance) {#momentum} - Applied security updates to latest build - Last major release Sep 2025 > **Cadence:** 5 total versions · 0 majors in last 6 months · 218 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Depression Cognitive Research is an established medical app that is free with in-app purchases. > **Bottom Line:** The app provides a rigorous tool for neuroscience research, but its B2B-only trial structure prevents consumer growth, so the PM should pivot to a consumer-facing freemium model to capture individual users. **Best for:** Healthcare professionals, researchers, and individuals seeking to monitor or improve cognitive health through scientifically-validated digital tools. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Pivot trial model to a freemium consumer tier because the 10-license limit restricts individual adoption → increase user base — *The current 10-license trial is designed for B2B, which fails to capture individual users seeking cognitive health monitoring.* _(trade-off: deprioritize Pause B2B feature development — individual acquisition is the current growth bottleneck.)_ - [ ] [INVEST] [MEDIUM IMPACT] Ship gamified daily logging streaks because symptom-tracking rivals like mySugr use them to drive retention → increase session frequency — *Competitor analysis shows gamification is the primary mechanism for daily engagement in the medical-tracking space.* _(trade-off: deprioritize Deprioritize non-essential UI polish — retention mechanics are the higher-yield lever.)_ ### Feature Gaps vs Competitors - Gamified daily logging (available in mySugr but absent here) - Longitudinal symptom mapping (available in Migraine Buddy but absent here) - Real-time AI feedback (available in Sword Health but absent here) ### Outlook: Stable The medical-tracking market is shifting toward high-engagement, gamified experiences that prioritize daily habit formation. Without a pivot to consumer-facing features, this app will remain a niche research tool, missing the opportunity to capture the broader cognitive health market. - ⚪ Recent updates focused on stability and security, suggesting the app remains in a maintenance phase rather than active feature expansion. - 🔴 The absence of user ratings across platforms suggests a lack of organic discovery, which limits the potential for future revenue growth. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Freemium | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Depression Cognitive Research** (this app) | N/A/5 | N/A | CogniFit | | [VA: Health and Benefits](https://marlvel.ai/intel-report/medical/gov-va-vamobileapp) | 4.8/5 | N/A | US Department of Veterans Affairs (VA) | | [Sword Health: AI Care](https://marlvel.ai/intel-report/medical/com-swordhealth-guarda-ios) | 4.7/5 | Mixed | Sword Health, Inc | | [Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) | 4.7/5 | Upset | MediSafe Inc. | | [Kardia](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg) | 4.8/5 | N/A | AliveCor, Inc. | | [Spruce: Medical Communication](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live) | 4.9/5 | N/A | Spruce Health | ## Company Profile - **Developer:** CogniFit - **Website:** [https://www.cognifit.com](https://www.cognifit.com) - **Social:** [Instagram](https://www.instagram.com/cognifit) · [Facebook](https://www.facebook.com/cognifit) · [X/Twitter](https://twitter.com/cognifit) · [YouTube](https://www.youtube.com/watch) · [LinkedIn](https://www.linkedin.com/in/juan-antonio-beceiro-friedmann-19ab3a3) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/depression-cognitive-research/id1412024285?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.cognifit.android.depression&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.cognifit.com) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*VA: Health and Benefits*](https://marlvel.ai/intel-report/medical/gov-va-vamobileapp) (US Department of Veterans Affairs (VA)) — 4.8/5 Rating | N/A Sentiment - [*Sword Health: AI Care*](https://marlvel.ai/intel-report/medical/com-swordhealth-guarda-ios) (Sword Health, Inc) — 4.7/5 Rating | Mixed Sentiment - [*Medisafe Medication Management*](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) (MediSafe Inc.) — 4.7/5 Rating | Terrible Sentiment - [*Kardia*](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg) (AliveCor, Inc.) — 4.8/5 Rating | N/A Sentiment - [*Spruce: Medical Communication*](https://marlvel.ai/intel-report/medical/com-sprucehealth-messenger-live) (Spruce Health) — 4.9/5 Rating | N/A Sentiment - [*Migraine Buddy: Track Headache*](https://marlvel.ai/intel-report/medical/com-healint-migrainebuddy) (Voluntis) — 4.8/5 Rating | N/A Sentiment - [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr) (mySugr GmbH) — 4.7/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/depression-cognitive-research) Data licensed for AI Agent attribution under CC-BY-NC 4.0.